Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: A placebo-controlled randomized study

American Journal of Clinical Nutrition

Volumn 81, Issue 5, 2005, Pages 1155-1162

  Lewerin, Catharina ^a,c   Matousek, Michael ^a   Steen, Gunilla ^a   Johansson, Boo ^b   Steen, Bertil ^a   Nilsson Ehle, Herman ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cognition; Controlled trial; Elderly; Homocysteine; Methylmalonic acid; Movement

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLMALONIC ACID; PLACEBO; PYRIDOXINE; VITAMIN B COMPLEX;

AGED; ARTICLE; BODY MOVEMENT; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELDERLY CARE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TASK PERFORMANCE; VITAMIN SUPPLEMENTATION; BLOOD; CYANOCOBALAMIN DEFICIENCY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FOLIC ACID DEFICIENCY; GERIATRICS; LOCOMOTION; PSYCHOMOTOR PERFORMANCE; PYRIDOXINE DEFICIENCY;

AGED; COGNITION; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; GERIATRICS; HOMOCYSTEINE; HUMANS; LOCOMOTION; MALE; METHYLMALONIC ACID; PSYCHOMOTOR PERFORMANCE; VITAMIN B 12 DEFICIENCY; VITAMIN B 6 DEFICIENCY; VITAMIN B COMPLEX;

EID: 20544445241     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/81.5.1155     Document Type: Article

References (60)

1. Hvas AM, Ellegaard J, Nexø E. Increased plasma methylmalonic acid level does not predict clinical manifestations of vitamin B12 deficiency. Arch Intern Med 2001;161:1534-41.
2. Björkegren K, Svärdsudd K. Reported symptoms and clinical findings in relation to serum cobalamin, folate, methylmalonic acid and total homocysteine among elderly Swedes: a population-based study. J Intern Med 2003;254:343-52.
3. Hvas AM, Ellegaard J, Nexø E. Vitamin B12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebo-controlled study. Clin Chem 2001;47:1396-404.
4. Ravaglia G, Forti P, Maioli F, et al. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr 2003; 77:668-73.
5. Duthie SJ, Whalley LJ, Collins AR, Leaper S, Berger K, Deary IJ. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002;75:908-13.
6. Riggs KM, Spiro A III, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996;63:306-14.
7. Miller JW, Green R, Ramos MI, et al. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2003;78:441-7.
8. Prins ND, Den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002;59: 1375-80.
9. Budge M, Johnston C, Hogervorst E, et al. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann N Y Acad Sci 2000;903:407-10.
10. McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001;12:309-13.
11. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer' s disease. N Engl J Med 2002;346:476-83.
12. Teunissen CE, Blom AH, Van Boxtel MP, et al. Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. J Biol Chem 2003;7:153-9.
13. Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement Geriatr Cogn Disord 1999;10:12-20.
14. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998;13:235-9.
15. Joosten E, Lesaffre E, Riezler R, et al. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol [A] Biol Sci Med Sci 1997;52:M76-9.
16. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-55.
17. Refsum H, Smith AD. Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalamin. J Neurol Neurosurg Psychiatry 2003;74:959-61.
18. Nilsson K, Gustaf son L, Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001;16:609-14.
19. Lehmann M, Regland B, Blennow K, Gottfries CG. Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment. Dement Geriatr Cogn Disord 2003;16:145-50.
20. Martin DC, Francis J, Protetch J, Huff FJ. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992;40:168-72.
21. van Asselt DZ, Pasman JW, van Lier HJ, et al. Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons. J Gerontol [A] Biol Sci Med Sci 2001;56:M775-9.
22. Clarke R, Harrison G, Richards S. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med 2003;254:67-75.
23. Chandra RK. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition 2001;17:709-12.
24. Kuhn W, Roebroek R, Blom H, et al. Elevated plasma levels of homocysteine in Parkinson's disease. Eur Neurol 1998;40:225-7.
25. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry 2003; 54:363-75.
26. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci 2003;991:1-14.
27. Miller JW, Selhub J, Nadeau MR, Thomas CA, Feldman RG, Wolf PA. Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology 2003;60:1125-9.
28. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ, Buschke H. Abnormality of gait as a predictor of non-Alzheimer's dementia. N Engl J Med 2002;347:1761-8.
29. Kado DM, Bucur A, Selhub J, Rowe JW, Seeman T. Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging. Am J Med 2002;113:537-42.
30. Huang RF, Huang SM, Lin BS, Wei JS, Liu TZ. Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci 2001;68:2799-811.
31. Kruman II, Culmsee C, Chan SL, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000;20:6920-6.
32. White AR, Huang X, Jobling MF, et al. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J Neurochem 2001;76:1509-20.
33. Baig SM, Qureshi GA, Minami M. The interrelation between the deficiency of vitamin B12 and neurotoxicity of homocysteine with nitrite in some of neurologic disorders. Biogenic Amines 1998;14:1-14.
34. Lipton SA, Kim WK, Choi YB, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 1997;94:5923-8.
35. McDowell IF, Lang D. Homocysteine and endothelial dysfunction: a link with cardiovascular disease. J Nutr 2000;130:369S-72S.
36. Krumdieck CL, Prince CW. Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr 2000; 130:3658-8S.
37. Lewerin C, Nilsson-Ehle H, Matousek M, Lindstedt G, Steen B. Reduction of plasma homocysteine and serum methylmalonate concentrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: a randomised trial. Eur J Clin Nutr 2003; 57:1426-36.
38. Matousek M, Baba S, Sonn U, Johnels B, Steg G, Steen B. Motor function in 90-year olds measured by optoelectronic kinesiology and activities of daily living. Aging (Milano) 1994;6:444-50.
39. Guo X, Matousek M, Sonn U, Sundh V, Steen B. Self-reported and performance-based mobility related to instrumental activities of daily living in women aged 62 years and older. A population study. Aging (Milano) 2000;12:295-300.
40. Guo X, Matousek M, Sundh V, Steen B. Motor performance in relation to age, anthropometric characteristics, and serum lipids in women. J Gerontol [A] Biol Sci Med Sci 2002;57:M37-44.
41. Guo X, Steen B, Matousek M, et al. A population-based study on brain atrophy and motor performance in elderly women. J Gerontol [A] Biol Sci Med Sci 2001;56:M633-7.
42. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945;19:87-95.
43. Wechsler D. The measurement and appraisal of adult intelligence. Baltimore, MD: Williams & Wilkins; 1958.
44. Dureman I, Sälde H. Psykometriska och experimentalpsykologiska metoder för klinisk tillämpning. (Psychometric and experimental psychological methods for clinical application.) Stockholm, Sweden: Almqvist & Wiksell, 1959 (in Swedish).
45. Thurstone LL. Primary mental abilities. Psychometric monographs. Chicago, IL: University of Chicago Press, 1938:5.
46. Rasmussen K. Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem 1989;35:260-4.
47. Bald E, Sypniewski S. Ion-pair high-performance liquid chromatography of cysteine and metabolically related compounds in the form of their S-pyridinium derivates. J Chromatogr A 1994;676:321-30.
48. O'Brien P. Comparing two samples: extensions of the t, rank-sum, and log-rank tests. J Am Stat Assoc 1988;83:52-61.
49. Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983;249:2917-21.
50. Guo X, Skoog I, Matousek M, et al. A population-based study on motor performance and white matter lesions in older women. J Am Geriatr Soc 2000;48:967-70.
51. Johnels B, Ingvarsson PE, Thorselius M, Valls M, Steg G. Disability profiles and objective quantitative assessment in Parkinson's disease. Acta Neurol Scand 1989;79:227-38.
52. Matousek M, Wikkelso C, Blomsterwall E, Johnels B, Steg G. Motor performance in normal pressure hydrocephalus assessed with an opto-electronic measurement technique. Acta Neurol Scand 1995;91:500-5.
53. Matousek M. Movement performance in the elderly. Investigations with an optoelectronic technique. Academical thesis. Göteborg, Sweden: Vasastadens Bokbinderi AB, 1995.
54. Guo X. Movement performance in elderly women. Relation to neuro-imaging findings, medical conditions and activities of daily living. Academic thesis. Göteborg, Sweden: Vasastadens Bokbinderi AB, 2002.
55. Russell RM, Suter PM. Vitamin requirements of elderly people: an update. Am J Clin Nutr 1993;58:4-14.
56. Hathcock JN, Troendle GJ. Oral cobalamin for treatment of pernicious anemia? JAMA 1991;265:96-7.
57. de Bree A, van Dusseldorp M, Brouwer IA, van het Hof KH, Steegers-Theunissen RP. Folate intake in Europe: recommended, actual and desired intake. Eur J Clin Nutr 1997;51:643-60.
58. Clarke R. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. Br Med J 1998;316:894-8.
59. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001;358:2069-73.
60. Abyad A. Prevalence of vitamin B12 deficiency among demented patients and cognitive recovery with cobalamin replacement. J Nutr Health and Aging 2002;6:254-60.